Re:AlphaFold at CASP13: What just happened?
by HarryHirsch on Monday December 10, 2018 @11:51AM
(#18649173)
That's what people outside drug development think. Meanwhile, 70 % of all drugs fail at Stage 2 testing. That's right, experienced pharmacologists at established companies go forward with compounds they believe will succeed, and still in 2 out of 3 cases they are not better than placebo.
[ Parent
| on HN ]
Re:AlphaFold at CASP13: What just happened?
by beaconstudios on Monday December 10, 2018 @05:25PM
(#18651638)
I'd hasten to add it's the same in software. We think the experts are right on the edge of performance, accuracy, and success while using all the right tools - meanwhile from the inside, it's a shambles in all but the highest stakes environments with the most qualified teams.
Re:AlphaFold at CASP13: What just happened?
by letitgo12345 on Tuesday December 11, 2018 @11:06PM
(#18661317)
I think the parent is talking about expertise for protein structure prediction, not drug development